Regenerative Medicine Market to be Valued at USD 6.49 Billion by 2027 | The Escalating Burden of Chronic Diseases and Genetic Aberrations will be the Major Factor Driving the Industry Growth, says Emergen Research
February 04, 2021 07:46 ET
|
Emergen Research
Vancouver, British Columbia, Feb. 04, 2021 (GLOBE NEWSWIRE) -- The Global Regenerative Medicine Market is predicted to attain a market valuation of USD 6.49 billion by 2027, growing at a CAGR of...
Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market
February 01, 2021 17:16 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today...
Rafarma Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan
January 29, 2021 10:30 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce its joint venture with the entity known as The Pharmaceutical Industry Development...
Clinical Communication and Collaboration Market Size to Reach USD 5,029.8 Million By 2027 | Increasing Use of Connected Devices in Hospitals will be the Key Factor Driving the Industry Growth, States Reports and Data
January 29, 2021 07:11 ET
|
Reports and Data
New York, Jan. 29, 2021 (GLOBE NEWSWIRE) -- The global clinical communication and collaboration market is expected to reach a market size of USD 5,029.8 Million by 2027 and register a significantly...
Patient Registry Software Market Size to Reach USD 2.96 Bn by 2027 | Rising Incidence of Chronic Diseases and Increasing Initiatives Related to Value-Based Care will be the Key Factor Driving the Industry Growth, States Emergen Research
January 26, 2021 14:00 ET
|
Emergen Research
Vancouver, British Columbia, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The global patient registry software market is forecast to reach a value of USD 2.96 Billion by 2027, at a rapid and steady CAGR of...
Nanopharmaceutical Drugs Market Size To Be Worth USD 82.71 Billion by 2027 Growing at a CAGR of 7.3% | Emergen Research
December 21, 2020 19:00 ET
|
Emergen Research
Vancouver, British Columbia, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The global nanopharmaceutical drugs market is projected to be worth USD 82.71 Billion by 2027, according to the current analysis by...
QSAM Biosciences Advances Plan of Separation from Legacy Business
November 10, 2020 09:00 ET
|
QSAM Biosciences Inc.
Pharmaceutical Industry Experts Assume Leadership Roles at QSAM;Over $4M in Debt Eliminated from Balance Sheet Palm Beach, FL, Nov. 10, 2020 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM)...
RespireRx Pharmaceuticals Inc. Announces Appointment of David Dickason as Senior Vice President Pre-Clinical Product Development
September 25, 2020 09:10 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Sept. 25, 2020 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
In-Vitro Toxicology/Toxicity Testing Market To Reach USD 14.6 Billion By 2027 | Reports and Data
August 06, 2020 11:13 ET
|
Reports and Data
New York, Aug. 06, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the Global In-Vitro Toxicology/Toxicity Testing market was valued at USD 7.2 billion in 2019 and is...
New Axtria™ COVID-19 Webinar Explores Omnichannel Migration Trends In The Life Sciences Industry
July 21, 2020 10:51 ET
|
Axtria Inc.
Berkeley Heights, NJ, July 21, 2020 (GLOBE NEWSWIRE) -- Axtria, a global leader in cloud software and data analytics for the life sciences commercial business, is partnering with the Pharmaceutical...